Showing 23,074 news articles about PEP

Filters Content type: Editors' picks Topic: PEP

Post-exposure prophylaxis involves taking a 28-day course of anti-HIV drugs, after possible exposure to HIV. It may be used by healthcare workers (occupational PEP) or after sex (post-exposure prophylaxis after sexual exposure, PEPSE, also known as non-occupational PEP or nPEP).

Hepatitis C treatment

New Hepatitis C Treatment Too Pricey For All Patients

Editor's pick
KJZZ Radio
7 October 2014
Hepatitis C treatment

As Gilead Mulls Price of Next Hepatitis C Drug, Top Activist Refutes "Bogus" Math

Editor's pick
TheBody.com
24 September 2014
Hepatitis C treatment

Thousands register for new hepatitis C drug in Egypt sold at 99 percent discount

Editor's pick
Egyptian Streets
19 September 2014
Hepatitis C treatment

Gilead signs pact with 7 firms for cheap copies of hepatitis C drug

Editor's pick
Reuters
15 September 2014
Pharmaceutical industry

Gilead to raise price for new hepatitis C drug above $84000

Editor's pick
Reuters
15 September 2014
Hepatitis C treatment

Doctors Battle Insurers for Access to Pricey Hepatitis C Drugs

Editor's pick
Healthline
9 September 2014
Hepatitis C transmission & prevention

HIV-Negative Gay Men May Acquire Hepatitis C Sexually

Editor's pick
Aidsmeds.com
9 September 2014
Hepatitis C transmission & prevention

That holiday pedicure may leave you with hepatitis C

Editor's pick
Courier Mail
1 September 2014
Hepatitis B

One out of 10 Asian Americans has hepatitis B

Editor's pick
Philippine Star
27 August 2014
Hepatitis C treatment

Britain Has No Problem Paying for Expensive Hepatitis C Drugs

Editor's pick
Businessweek
19 August 2014
Hepatitis C treatment

UK cost body backs pricey Gilead hepatitis pill for some patients

Editor's pick
Reuters
15 August 2014
Hepatitis C treatment

Vertex to stop selling hepatitis C drug Incivek, once a blockbuster, in October

Editor's pick
Boston Business Journal (blog)
13 August 2014
Prisoners

Why the Hepatitis Cure Sovaldi Is a Budgetary Disaster for Prisons

Editor's pick
New York Times
7 August 2014
Hepatitis C treatment

J&J beats forecasts, helped by new hepatitis C drug

Editor's pick
Reuters
16 July 2014
Hepatitis C treatment

EU nations join forces against 'exorbitant' hepatitis C drug: France

Editor's pick
Medical Xpress
10 July 2014
Hepatitis C treatment

2014 UK Consensus Guidelines — Hepatitis C Management and Direct-acting Anti-viral Therapy

Editor's pick
Medscape (requires registration)
19 June 2014
New & experimental hepatitis C treatment

AbbVie all-oral hepatitis C therapy gets rapid EU review

Editor's pick
Reuters
17 June 2014
Pharmaceutical industry

FDA lifts hold on Achillion's hepatitis C drug, shares jump

Editor's pick
Reuters
11 June 2014
Hepatitis C treatment

Why The Hepatitis C Cost Cutters May Have Already Lost

Editor's pick
Forbes
11 June 2014
New & experimental hepatitis C treatment

Why Merck Just Spent $4 Billion On New Drugs For Hepatitis C

Editor's pick
Forbes
9 June 2014
Access to healthcare

Hepatitis Warrior Hiking in China Shows Glaxo Hurdles

Editor's pick
Bloomberg
30 May 2014
Hepatitis C treatment

US health insurers say Gilead hepatitis C drug too costly

Editor's pick
Reuters
21 May 2014
Hepatitis B

Hepatitis B a growing problem in UK prisons

Editor's pick
The Independent
1 May 2014
Pharmaceutical industry

Gilead Beats Hepatitis C Sales Estimates by $1 Billion

Editor's pick
Bloomberg
23 April 2014